STAAR Surgical Company STAA

Company Overview

STAAR Surgical Company is a U.S.-based medical device manufacturer focused on ophthalmic technologies, primarily implantable lenses used in refractive vision correction procedures. The company operates within the global ophthalmology and elective vision correction markets, with its core business centered on the development, manufacture, and commercialization of implantable collamer lenses (ICLs) for myopia, hyperopia, astigmatism, and presbyopia treatment. Its flagship product line, the EVO family of implantable lenses, is designed as an alternative to corneal refractive procedures such as LASIK and PRK. Revenue is primarily generated through sales of implantable lenses and related surgical products to ophthalmic surgeons, clinics, and distributors.

The company has established a differentiated position through its proprietary Collamer material technology and specialization in phakic intraocular lenses. STAAR Surgical was founded in 1982 and initially focused on intraocular lens technologies before shifting strategic emphasis toward refractive implantable lenses. Over time, the company expanded internationally, particularly across Asian markets where demand for myopia correction procedures has grown significantly. Public filings and investor materials indicate that the company’s long-term strategy centers on premium refractive surgery solutions and surgeon adoption of EVO ICL procedures.